News & Articles

EPISEQ SARS-COV-2 will support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants

The drug candidate was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated

The system is now in daily use at CaroMont Regional Medical Center

The research could not only affect food supply for animals and humans, but also potentially have environmental effects on greenhouse gases

Variation in the response of chickens to Campylobacter helps identify key genes that may provide resistance to infection

The autonomous cellufacturing facility aims to enable continuously scalable, cost-effective, automated food scale production of cell cultured human milk

Scientists detect a key molecular property of all living organisms from a helicopter flying several kilometers above ground.

The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target

Solutions to complement Company’s growing position in cell and gene therapy research and development

The expanded agreement grants Iksuda access to LegoChem Biosciences’ next generation ADC platform for up to six targets

The new standard for fish packaging

The machines are officially certified with My Green Lab’s coveted ‘Eco-Nutrition’ label

The consortium will assess multiple new or existing process analytical technologies (PAT), including HORIBA’s A-TEEM™ fluorescence technology

Consortium formed to lower costs of cell and gene therapies through process development and manufacturing collaborations

The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality

Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot-dissolving drug, which include bleeding on the brain

It is hoped the project will lead to improved quality of life for patients

OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients